RSH - media / research, page-28

(RSH:ASX) Road Show

Respiri recently acquired the #remotepatientmonitoring business Access Managed Services.

Presentations in Melbourne, Sydney and Virtually over the week of 12-15 September to highlight the new #valueproposition the combination brings investors.

Respiri's move into RPM is to leverage the successful #FDA approval and #reimbursement codes for Wheezo, its #medtech device, and move into the high revenue, high gross profit margin RPM industry.

The company is also leveraging the proven capability of Marjan Mikel (he has been there and done that) and the opportunity to expand into #CardioVascular, #COPD and #Diabetes with the RPM service.

★ Melbourne, Tuesday, 12 September, 8am – 5pm
★ Sydney, Wednesday, 13 September, 8am – 6pm
★ Virtual, Thursday, 14 September & Friday, 15 September

Please either comment or message me to arrange an appointment.

Respiri's acquisition of Access Managed Services looks to build volume and value by reducing hospital re-admissions. This is a high-cost issue for Governments, insurers, hospitals and patients, and the requirement for action from these parties has been driven by legislation. The US Centers for Medicare & Medicaid Services (#cms ) now fines poor-performing Hospitals for failing to meet lower re-admission targets under the Affordable Care Act (#affordablecareact).

Respiri's acquisition of Access Managed Services and its Remote Patient Monitoring (RPM) business leverages the benefits of Wheezo, its Asthma and COPD MedTech device. The new services of the combined entity are expected to drive the company's revenue expansion by helping to reduce hospital re-admission rates in the US.

Why is RPM needed?
✔ 2,250 hospitals (42%) in the US were fined for excessive re-admission rates (patient returns within 30 days)
✔ The US government has introduced the Hospital Re-admissions Reduction Program (HRRP) under the Affordable Care Act
✔ Hospitals and insurers have been told to focus on quality rather than quantity of care.
✔ Preventable rehospitalisation costs Medicare hundreds of millions of dollars each year.